Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
Poster Session II - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.01 - ACUTE MANAGEMENT - Neither thrombolysis nor thrombectomy P654 - ESOC25-1345 THE METOCLOPRAMIDE FOR AVOIDING PNEUMONIA AFTER STROKE (MAPS-2): A SINGLE-BLIND RANDOMIZED CONTROLLED TRIAL OF METOCLOPRAMIDE FOR PREVENTION OF PNEUMONIA AFTER STROKE Anushka Warusevitane 1 , Craig Smith 2 , Anand Dixit 3 , Nikola Sprigg 4 , Reuben Ogollah 5 , Julius Sim 6 , Sue Jowett 7 , Diane Havard 4 , Lesia Kurlak 4 , Rebecca Ward 4 , Jared Palmer 4 , Iris Isheanesu Mhlanga 4 , Corinne Latulipe 4 , Lee Haywood 4 , Lisa Woodhouse 4 , Philip Bath 4 , Christine Roffe 1,6 1 Royal Stoke University Hospital, Stoke on Trent, United Kingdom, 2 Division of Cardiovascular Sciences, University of Manchester, Manchester, United Kingdom, 3 Freeman Hospital, Newcastle upon Tyne, United Kingdom, 4 Stroke Trials Unit, Mental Health and Clinical Neurosciences, University of Nottingham, Nottingham, United Kingdom, 5 Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, United Kingdom, 6 School of Medicine, Keele University, Keele, United Kingdom, 7 Health Economics Unit, University of Birmingham, Birmingham, United Kingdom Background and Aims: Pneumonia causes more deaths than neurological damage after stroke
How long does it take to see results from CJC or CJC1295 with DAC
If your child is truly uncomfortable, talk with your pediatrician about whether short-term symptom relief (such as antihistamines) is appropriate
If your rotator cuff pain fails to improve in the initial stages, worsens with time, or develops any concerning symptoms (such as arm numbness or weakness), it is advisable to consult a physician for further evaluation and treatment
